v3.25.2
Stock-Based Compensation (Tables)
12 Months Ended
Mar. 31, 2025
Share-Based Payment Arrangement [Abstract]  
Schedule of weighted-average assumptions of fair value of employee stock options
        
   Year Ended March 31, 
   2025   2024 
Fair value of the Company’s common stock on date of grant  $2.68   $0.19 
Expected term   5.68 yrs    5.56 yrs 
Risk-free interest rate   4.57%    3.87% 
Dividend yield   0.00%    0.00% 
Volatility   109.91%    98.40% 
Fair value of options granted  $2.23   $0.15 
Schedule of stock based awards outstanding by plan
    
Plan  Stock Options 
2011 Plan   3,998 
2016 Plan   38,942 
2021 Plan   30,141 
    73,081 
Schedule of options activity
                    
   Number of
Shares
   Weighted-
Average
Exercise Price
   Weighted-
Average
Contractual Term
   Aggregate
Intrinsic
Value
 
Outstanding at April 1, 2024   51,675   $62.60           
Options granted   49,500    2.68           
Options exercised   (27,750)   2.99           
Options forfeited   (250)   3.60           
Options expired   (94)   1,485.96           
Outstanding at March 31, 2025   73,081   $43.27    8.82   $2.19 
Exercisable at March 31, 2025   39,751   $74.86    7.71   $2.19 
Schedule of unvested restricted stock activity
          
  

Number of

Shares

  

Weighted

Average Award

Date Fair Value

per Share

 
Unvested restricted stock awards outstanding at April 1, 2024      $ 
Restricted stock awards granted   54,538    2.92 
Restricted stock awards vested   (9,538)   4.08 
Unvested restricted stock awards outstanding at March 31, 2025   45,000   $2.68